• Bayer, Abbott Billion-Dollar Mass-Tort Risk

  • Sep 12 2024
  • Length: 27 mins
  • Podcast

Bayer, Abbott Billion-Dollar Mass-Tort Risk

  • Summary

  • Companies facing multibillion-dollar exposure from mass-tort personal-injury litigation have faced massive jury verdicts in 2024. In this Votes and Verdicts episode, BI litigation analyst Holly Froum is joined by mass-tort expert and attorney Joseph Fantini to discuss some of the major litigation facing consumer and industrial companies, including cancer claims against Bayer’s Monsanto weedkiller, Zantac lawsuits against drugmakers GSK and others, NEC litigation against Abbott and Reckitt’s Mead Johnson unit and PFAS cases against 3M and other manufacturers. They discuss potential catalysts, the strength of cases, as well as likelihood of potential global settlements.

    See omnystudio.com/listener for privacy information.

    Show More Show Less
activate_samplebutton_t1

What listeners say about Bayer, Abbott Billion-Dollar Mass-Tort Risk

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.